Covidien (Dublin, Ireland) said it has overcame a significant roadblock to predictable ablation of soft tissue with its new advanced ablation system. According to the company, the system offers physicians predictable results regardless of the target location or tissue type. The Emprint ablation system with Thermosphere technology is designed to precisely heat and destroy diseased soft tissue (including liver, lung and kidney), and non-resectable liver tumors.